Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors.
Authors
Celine Yeh
Memorial Sloan Kettering Cancer Center, New York, NY
Celine Yeh , Christopher Cowley , Amitabh Srivastava , Walid Khaled Chatila , Dorina Ismailgeci , Joanne F. Chou , Marinela Capanu , Manish A. Shah , Francisco Sanchez-Vega , Karuna Ganesh , David Paul Kelsen , Rona Yaeger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 37)
DOI
10.1200/JCO.2024.42.3_suppl.37
Abstract #
37
Poster Bd #
C18
Abstract Disclosures
Similar Posters
First Author: Sandra Algaze
Poster
2021 ASCO Annual Meeting
A large real-world study on the effectiveness of the combined inhibition of EGFR and MET in EGFR-mutant advanced non-small cell lung cancer (NSCLC).
First Author: Liu Li
Poster
2014 ASCO Annual Meeting
Molecular profiling of 6,892 colorectal cancer patients to identify potential treatment options.
First Author: Wafik S. El-Deiry
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff